Highlights
1 patent
About
Noninvasive Magnetic Therapy for Dry Eye Disease
Epitech MAG develops a noninvasive medical device and method for the treatment of dry eye syndrome. The company's noninvasive ocular neurostimulation therapy is designed to treat the entire ocular surface and tear film by enabling zero-contact, affordable, easily adopted procedures for long-lasting relief from dry eye symptoms. Epitech's proprietary technology is based on repetitive magnetic stimulation, which uses targeted magnetic fields to stimulate the peripheral branches of the trigeminal nerve, resulting in the reinforcement of the ocular surface's structural integrity.
Identity
| Name | EpiTech MAG |
|---|---|
| Slug | epitech-mag |
| Type / kind | startup |
| Crunchbase ID | epitech-3 |
| Source _id | agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgLmbjNMKDA |
Status
| Status | inactive |
|---|---|
| Status reason | Non Active, Sep 2022 ceased to operate |
| Last update | 2026-05-17 |
Location
| HQ country code | IL |
|---|---|
| HQ region/district | Center District |
| HQ city | Kefar Sava |
| HQ address | Atir Yeda St 16, Kfar Saba, Israel |
Web & social
| https://www.linkedin.com/company/17942686 | |
| YouTube | https://www.youtube.com/channel/UCbJp_V6Q5FH6WCsuADiYt7A |
Classifications
Primary sector Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesMedical Treatment & Therapeutics
Target customers
Healthcare & Life SciencesHealthcareProviders
Business models
B2B
Tags
medical-deviceshealthcare-providersnon-invasiveophthalmologyeye-diseasesbioconvergence
Funding
| Total raised | $2.0M |
|---|---|
| Current stage | Series A |
Raw source document
Show full JSON (0 KB)
{
"0": "s",
"1": "l",
"2": "i",
"3": "m",
"4": "p",
"5": "a",
"6": "g",
"7": "e",
"8": "s",
"9": "_",
"10": "i",
"11": "m",
"12": "p",
"13": "o",
"14": "r",
"15": "t"
}